ICER is a trusted non-profit organization that evaluates evidence on the value of medical tests, treatments and delivery system innovations and moves that evidence into action to improve the health care system. To accomplish this goal ICER performs analyses on effectiveness and costs; develops reports using innovative methods that make (more…)
The results for the 2017 CIHR-PHSI for Cancer Control research have been formally announced, and ARCC is proud to have significant involvement in the work to come. Four of the six announced projects are led by ARCC members, including projects headed by both ARCC co-directors. This represents a significant investment by (more…)
re-posted from http://www.partnershipagainstcancer.ca/new-vice-president-cancer-control/ The Canadian Partnership Against Cancer (the Partnership) has announced the appointment of Dr. Craig Earle as Vice-President, Cancer Control effective November 1, 2017.
In a recent paper published in the Journal of Clinical Oncology and supported by ARCC, researchers examined whether the ASCO Value Framework and the ESMO Magnitude of Clinical Benefit Scale measure similar constructs of clinical benefit. They also looked at how both relate to quality-adjusted life-years, and funding recommendations in (more…)
We are pleased to share with you the final report on the “Making Fair & Sustainable Decisions about Funding for Cancer Drugs” collaboration. This collaboration was funded by the Canadian Partnership Against Cancer, supporting ARCC and the McMaster Health Forum. We invite you to read and download a copy today! (more…)
Click here to view this opportunity on CIHR’s websiteCIHR and other funding agencies have invested in the establishment of cohorts and databases. These cohorts and databases house high quality health systems and patient data sets and/or biospecimens. As such, there exists a wealth of information that has the (more…)
Effective health care integrates palliative care into the patients’ treatment plan as early as possible, but Palliative and End-of-Life Care: A Cancer System Performance Report suggests this may not always be happening in Canada. Palliative care is not limited to end-of-life care; it is effective for pain and symptom management (more…)
Post-Doctoral Fellow, Reference #60724 Temporary Full Time (2 year term), Vancouver, BC The candidate will work with a team of world-class Scientists at the BC Cancer Agency (BCCA) for the Canadian Centre for Applied Research in Cancer Control (ARCC). ARCC is an innovative pan-Canadian research (more…)